Results for tag: "Elagolix"

Elagolix is a drug used to treat endocrine and metabolic disorders. It is a gonadotropin-releasing hormone (GnRH) antagonist, which works by blocking the action of GnRH, a hormone that stimulates the release of other hormones. This reduces the production of hormones that can cause symptoms of endocrine and metabolic disorders. Elagolix is used to treat endometriosis, uterine fibroids, and polycystic ovary syndrome (PCOS). It is also being studied for its potential to treat other conditions, such as obesity and type 2 diabetes. Elagolix is marketed by several companies, including AbbVie, Allergan, and Myovant Sciences. AbbVie markets Elagolix under the brand name Orilissa, while Allergan markets it under the brand name Vylessi. Myovant Sciences markets Elagolix under the brand name Relugolix. Show Less Read more